The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 02, 2021

Filed:

Aug. 03, 2016
Applicants:

Novartis Ag, Basel, CH;

Nelson Guerreiro, Basel, CH;

Christophe Meille, Sierentz, FR;

Jens Wuerthner, Steinen, DE;

Inventors:

Nelson Guerreiro, Basel, CH;

Christophe Meille, Sierentz, FR;

Jens Wuerthner, Steinen, DE;

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); A61P 35/00 (2006.01); G01N 33/50 (2006.01); A61K 31/47 (2006.01); A61K 31/4439 (2006.01); A61K 31/501 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5014 (2013.01); A61K 31/4439 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61K 31/501 (2013.01); A61P 35/00 (2018.01); G01N 33/5088 (2013.01); C12Q 2600/142 (2013.01); G01N 2333/46 (2013.01); G01N 2333/495 (2013.01); G01N 2800/222 (2013.01); G01N 2800/50 (2013.01);
Abstract

The present disclosure relates to use of GDF-15 as a safety biomarker for determining a toxicological effect of a Mdm2 inhibitor; an ex vivo method for determining a toxicological effect of a Mdm2 inhibitor in a subject, in particular for determining a likelihood of developing thrombocytopenia in a subject in response to administration of a dose of a Mdm2 inhibitor; methods of using a Mdm2 inhibitor in the treatment of cancer in a subject; a kit for use in predicting the likelihood that a patient having cancer will develop thrombocytopenia in response to a treatment with a dose of a Mdm2 inhibitor; a kit for use in treating a patient having cancer and related disclosure embodiments.


Find Patent Forward Citations

Loading…